Long-acting Injectable Medications Market, Global Outlook and Forecast 2022-2028

February 2022 | 67 pages | ID: L3170884B53DEN
Market Monitor Global

Abstracts

Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.

This report contains market size and forecasts of Long-acting Injectable Medications in Global, including the following market information:

Global Long-acting Injectable Medications Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Long-acting Injectable Medications market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

First-generation Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Long-acting Injectable Medications include Eli Lilly, Alkermes, Johnson & Johnson, Zogenix, DURECT, Mapi Pharma, GSK, MedinCell and Oakwood Labs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Long-acting Injectable Medications companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Long-acting Injectable Medications Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Long-acting Injectable Medications Market Segment Percentages, by Type, 2021 (%)

• First-generation
• Second-generation

Global Long-acting Injectable Medications Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Long-acting Injectable Medications Market Segment Percentages, by Application, 2021 (%)

• Schizophrenia
• Contraception
• HIV
• Others

Global Long-acting Injectable Medications Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Long-acting Injectable Medications Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Long-acting Injectable Medications revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Long-acting Injectable Medications revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Alkermes
• Johnson & Johnson
• Zogenix
• DURECT
• Mapi Pharma
• GSK
• MedinCell
• Oakwood Labs
• Nanomi
• Pharmathen
• Kashiv BioSciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Long-acting Injectable Medications Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Long-acting Injectable Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LONG-ACTING INJECTABLE MEDICATIONS OVERALL MARKET SIZE

2.1 Global Long-acting Injectable Medications Market Size: 2021 VS 2028
2.2 Global Long-acting Injectable Medications Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Long-acting Injectable Medications Players in Global Market
3.2 Top Global Long-acting Injectable Medications Companies Ranked by Revenue
3.3 Global Long-acting Injectable Medications Revenue by Companies
3.4 Top 3 and Top 5 Long-acting Injectable Medications Companies in Global Market, by Revenue in 2021
3.5 Global Companies Long-acting Injectable Medications Product Type
3.6 Tier 1, Tier 2 and Tier 3 Long-acting Injectable Medications Players in Global Market
  3.6.1 List of Global Tier 1 Long-acting Injectable Medications Companies
  3.6.2 List of Global Tier 2 and Tier 3 Long-acting Injectable Medications Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Long-acting Injectable Medications Market Size Markets, 2021 & 2028
  4.1.2 First-generation
  4.1.3 Second-generation
4.2 By Type - Global Long-acting Injectable Medications Revenue & Forecasts
  4.2.1 By Type - Global Long-acting Injectable Medications Revenue, 2017-2022
  4.2.2 By Type - Global Long-acting Injectable Medications Revenue, 2023-2028
  4.2.3 By Type - Global Long-acting Injectable Medications Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Long-acting Injectable Medications Market Size, 2021 & 2028
  5.1.2 Schizophrenia
  5.1.3 Contraception
  5.1.4 HIV
  5.1.5 Others
5.2 By Application - Global Long-acting Injectable Medications Revenue & Forecasts
  5.2.1 By Application - Global Long-acting Injectable Medications Revenue, 2017-2022
  5.2.2 By Application - Global Long-acting Injectable Medications Revenue, 2023-2028
  5.2.3 By Application - Global Long-acting Injectable Medications Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Long-acting Injectable Medications Market Size, 2021 & 2028
6.2 By Region - Global Long-acting Injectable Medications Revenue & Forecasts
  6.2.1 By Region - Global Long-acting Injectable Medications Revenue, 2017-2022
  6.2.2 By Region - Global Long-acting Injectable Medications Revenue, 2023-2028
  6.2.3 By Region - Global Long-acting Injectable Medications Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Long-acting Injectable Medications Revenue, 2017-2028
  6.3.2 US Long-acting Injectable Medications Market Size, 2017-2028
  6.3.3 Canada Long-acting Injectable Medications Market Size, 2017-2028
  6.3.4 Mexico Long-acting Injectable Medications Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Long-acting Injectable Medications Revenue, 2017-2028
  6.4.2 Germany Long-acting Injectable Medications Market Size, 2017-2028
  6.4.3 France Long-acting Injectable Medications Market Size, 2017-2028
  6.4.4 U.K. Long-acting Injectable Medications Market Size, 2017-2028
  6.4.5 Italy Long-acting Injectable Medications Market Size, 2017-2028
  6.4.6 Russia Long-acting Injectable Medications Market Size, 2017-2028
  6.4.7 Nordic Countries Long-acting Injectable Medications Market Size, 2017-2028
  6.4.8 Benelux Long-acting Injectable Medications Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Long-acting Injectable Medications Revenue, 2017-2028
  6.5.2 China Long-acting Injectable Medications Market Size, 2017-2028
  6.5.3 Japan Long-acting Injectable Medications Market Size, 2017-2028
  6.5.4 South Korea Long-acting Injectable Medications Market Size, 2017-2028
  6.5.5 Southeast Asia Long-acting Injectable Medications Market Size, 2017-2028
  6.5.6 India Long-acting Injectable Medications Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Long-acting Injectable Medications Revenue, 2017-2028
  6.6.2 Brazil Long-acting Injectable Medications Market Size, 2017-2028
  6.6.3 Argentina Long-acting Injectable Medications Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Long-acting Injectable Medications Revenue, 2017-2028
  6.7.2 Turkey Long-acting Injectable Medications Market Size, 2017-2028
  6.7.3 Israel Long-acting Injectable Medications Market Size, 2017-2028
  6.7.4 Saudi Arabia Long-acting Injectable Medications Market Size, 2017-2028
  6.7.5 UAE Long-acting Injectable Medications Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Long-acting Injectable Medications Major Product Offerings
  7.1.4 Eli Lilly Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Alkermes
  7.2.1 Alkermes Corporate Summary
  7.2.2 Alkermes Business Overview
  7.2.3 Alkermes Long-acting Injectable Medications Major Product Offerings
  7.2.4 Alkermes Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.2.5 Alkermes Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Long-acting Injectable Medications Major Product Offerings
  7.3.4 Johnson & Johnson Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Key News
7.4 Zogenix
  7.4.1 Zogenix Corporate Summary
  7.4.2 Zogenix Business Overview
  7.4.3 Zogenix Long-acting Injectable Medications Major Product Offerings
  7.4.4 Zogenix Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.4.5 Zogenix Key News
7.5 DURECT
  7.5.1 DURECT Corporate Summary
  7.5.2 DURECT Business Overview
  7.5.3 DURECT Long-acting Injectable Medications Major Product Offerings
  7.5.4 DURECT Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.5.5 DURECT Key News
7.6 Mapi Pharma
  7.6.1 Mapi Pharma Corporate Summary
  7.6.2 Mapi Pharma Business Overview
  7.6.3 Mapi Pharma Long-acting Injectable Medications Major Product Offerings
  7.6.4 Mapi Pharma Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.6.5 Mapi Pharma Key News
7.7 GSK
  7.7.1 GSK Corporate Summary
  7.7.2 GSK Business Overview
  7.7.3 GSK Long-acting Injectable Medications Major Product Offerings
  7.7.4 GSK Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.7.5 GSK Key News
7.8 MedinCell
  7.8.1 MedinCell Corporate Summary
  7.8.2 MedinCell Business Overview
  7.8.3 MedinCell Long-acting Injectable Medications Major Product Offerings
  7.8.4 MedinCell Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.8.5 MedinCell Key News
7.9 Oakwood Labs
  7.9.1 Oakwood Labs Corporate Summary
  7.9.2 Oakwood Labs Business Overview
  7.9.3 Oakwood Labs Long-acting Injectable Medications Major Product Offerings
  7.9.4 Oakwood Labs Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.9.5 Oakwood Labs Key News
7.10 Nanomi
  7.10.1 Nanomi Corporate Summary
  7.10.2 Nanomi Business Overview
  7.10.3 Nanomi Long-acting Injectable Medications Major Product Offerings
  7.10.4 Nanomi Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.10.5 Nanomi Key News
7.11 Pharmathen
  7.11.1 Pharmathen Corporate Summary
  7.11.2 Pharmathen Business Overview
  7.11.3 Pharmathen Long-acting Injectable Medications Major Product Offerings
  7.11.4 Pharmathen Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.11.5 Pharmathen Key News
7.12 Kashiv BioSciences
  7.12.1 Kashiv BioSciences Corporate Summary
  7.12.2 Kashiv BioSciences Business Overview
  7.12.3 Kashiv BioSciences Long-acting Injectable Medications Major Product Offerings
  7.12.4 Kashiv BioSciences Long-acting Injectable Medications Revenue in Global Market (2017-2022)
  7.12.5 Kashiv BioSciences Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Long-acting Injectable Medications Market Opportunities & Trends in Global Market
Table 2. Long-acting Injectable Medications Market Drivers in Global Market
Table 3. Long-acting Injectable Medications Market Restraints in Global Market
Table 4. Key Players of Long-acting Injectable Medications in Global Market
Table 5. Top Long-acting Injectable Medications Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Long-acting Injectable Medications Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Long-acting Injectable Medications Revenue Share by Companies, 2017-2022
Table 8. Global Companies Long-acting Injectable Medications Product Type
Table 9. List of Global Tier 1 Long-acting Injectable Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Long-acting Injectable Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Long-acting Injectable Medications Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Long-acting Injectable Medications Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Long-acting Injectable Medications Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Long-acting Injectable Medications Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Long-acting Injectable Medications Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Long-acting Injectable Medications Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Long-acting Injectable Medications Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Long-acting Injectable Medications Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Long-acting Injectable Medications Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Long-acting Injectable Medications Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Long-acting Injectable Medications Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Long-acting Injectable Medications Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Long-acting Injectable Medications Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Long-acting Injectable Medications Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Long-acting Injectable Medications Product Offerings
Table 32. Eli Lilly Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 33. Alkermes Corporate Summary
Table 34. Alkermes Long-acting Injectable Medications Product Offerings
Table 35. Alkermes Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Long-acting Injectable Medications Product Offerings
Table 38. Johnson & Johnson Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 39. Zogenix Corporate Summary
Table 40. Zogenix Long-acting Injectable Medications Product Offerings
Table 41. Zogenix Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 42. DURECT Corporate Summary
Table 43. DURECT Long-acting Injectable Medications Product Offerings
Table 44. DURECT Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 45. Mapi Pharma Corporate Summary
Table 46. Mapi Pharma Long-acting Injectable Medications Product Offerings
Table 47. Mapi Pharma Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 48. GSK Corporate Summary
Table 49. GSK Long-acting Injectable Medications Product Offerings
Table 50. GSK Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 51. MedinCell Corporate Summary
Table 52. MedinCell Long-acting Injectable Medications Product Offerings
Table 53. MedinCell Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 54. Oakwood Labs Corporate Summary
Table 55. Oakwood Labs Long-acting Injectable Medications Product Offerings
Table 56. Oakwood Labs Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 57. Nanomi Corporate Summary
Table 58. Nanomi Long-acting Injectable Medications Product Offerings
Table 59. Nanomi Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 60. Pharmathen Corporate Summary
Table 61. Pharmathen Long-acting Injectable Medications Product Offerings
Table 62. Pharmathen Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)
Table 63. Kashiv BioSciences Corporate Summary
Table 64. Kashiv BioSciences Long-acting Injectable Medications Product Offerings
Table 65. Kashiv BioSciences Long-acting Injectable Medications Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Long-acting Injectable Medications Segment by Type in 2021
Figure 2. Long-acting Injectable Medications Segment by Application in 2021
Figure 3. Global Long-acting Injectable Medications Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Long-acting Injectable Medications Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Long-acting Injectable Medications Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Long-acting Injectable Medications Revenue in 2021
Figure 8. By Type - Global Long-acting Injectable Medications Revenue Market Share, 2017-2028
Figure 9. By Application - Global Long-acting Injectable Medications Revenue Market Share, 2017-2028
Figure 10. By Region - Global Long-acting Injectable Medications Revenue Market Share, 2017-2028
Figure 11. By Country - North America Long-acting Injectable Medications Revenue Market Share, 2017-2028
Figure 12. US Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Long-acting Injectable Medications Revenue Market Share, 2017-2028
Figure 16. Germany Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 17. France Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Long-acting Injectable Medications Revenue Market Share, 2017-2028
Figure 24. China Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 28. India Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Long-acting Injectable Medications Revenue Market Share, 2017-2028
Figure 30. Brazil Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Long-acting Injectable Medications Revenue Market Share, 2017-2028
Figure 33. Turkey Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Long-acting Injectable Medications Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alkermes Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Zogenix Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. DURECT Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mapi Pharma Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GSK Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MedinCell Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Oakwood Labs Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Nanomi Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Pharmathen Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Kashiv BioSciences Long-acting Injectable Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)